Lupus Research Alliance and Lupus Therapeutics Partner on New Phase 3 Trial Testing Potential Benefit of Ustekinumab (Stelara®) in Lupus
The Lupus Research Alliance announced that clinical research affiliate Lupus Therapeutics is partnering with the pharmaceutical company, Janssen, to help conduct a Phase 3 trial to test existing drug ustekinumab (Stelara®) as a potential treatment for people with lupus. Stelara® is not approved by the FDA as a treatment of lupus but is indicated for […] Read More